Related Funds
| Fund Name | Location |
| 2048 Ventures | New York, New York, United States |
| Action Hero Ventures | South Africa, Stellenbosch, Western Cape |
| Catalyst Romania | Bucharest, Bucuresti, Romania |
| Crescat Capital | Colorado, Denver, United States |
| Electrosonic | Burbank, California, United States |
| Graham Partners | Newtown Square, Pennsylvania, United States |
| Haida Lianchuang Wuhan Touzi | China, Hubei, Wuhan |
| Haitong Securities | China, Shanghai |
| Keiyo Gas | Chiba Prefecture, Ichikawa, Japan |
| Koerner Capital | Louisiana, New Orleans, United States |
| Milcom Technologies | - |
| NOS Ventures | California, San Francisco, United States |
| Qingdao Xiangbai | China, Qingdao Shi, Shandong |
| Rumford | Bavaria, Germany, Munich |
| Seazen | China, Guangxi, Zhongjiang |
| Shanghai Healthcare Capital | - |
| Soses Investments | Netherlands, Noord-Holland, North Holland |
| Yixin Touzi | Beijing, Beijing, China |
| Youget Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AgenDx Biosciences | $675K | 07 Feb 2018 | South Bend, Indiana, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AgenDx Biosciences | $675K | 07 Feb 2018 | South Bend, Indiana, United States |
